Sharma East India Hospitals & Medical Research Ltd (BOM:524548)
India
· Delayed Price · Currency is INR 103.00
-0.05 (-0.05%)
At close: Apr 28, 2026
BOM:524548 Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Operating Revenue | 344.51 | 298.72 | 185.23 | 207.26 | 170.38 | 81.31 | Upgrade
|
| Revenue | 344.51 | 298.72 | 185.23 | 207.26 | 170.38 | 81.31 | Upgrade
|
| Revenue Growth (YoY) | 34.11% | 61.27% | -10.63% | 21.64% | 109.56% | -49.71% | Upgrade
|
| Cost of Revenue | 147.25 | 107.19 | 58.13 | 67.01 | 53.46 | 27.91 | Upgrade
|
| Gross Profit | 197.26 | 191.54 | 127.1 | 140.24 | 116.92 | 53.4 | Upgrade
|
| Selling, General & Admin | 133.61 | 122.6 | 123.37 | 84.38 | 67.76 | - | Upgrade
|
| Other Operating Expenses | 29.27 | 32.42 | 22.5 | 22.86 | 26.6 | 59.97 | Upgrade
|
| Operating Expenses | 182.44 | 173.39 | 160.66 | 121.14 | 102.16 | 66.42 | Upgrade
|
| Operating Income | 14.82 | 18.15 | -33.56 | 19.1 | 14.75 | -13.03 | Upgrade
|
| Interest Expense | -4.06 | -6.33 | -8.36 | -11.81 | -7.02 | -6.94 | Upgrade
|
| Interest & Investment Income | 1.58 | 1.58 | 0.84 | - | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | -0.26 | -0.81 | -1.11 | 0.64 | 0.59 | 28.33 | Upgrade
|
| EBT Excluding Unusual Items | 12.08 | 12.59 | -42.19 | 7.93 | 8.32 | 8.37 | Upgrade
|
| Gain (Loss) on Sale of Assets | 1.54 | 1.54 | 52.23 | - | - | - | Upgrade
|
| Pretax Income | 13.62 | 14.13 | 10.04 | 7.93 | 8.32 | 8.37 | Upgrade
|
| Income Tax Expense | 1.81 | 1.69 | 3.41 | -0.41 | 1.52 | 1.99 | Upgrade
|
| Net Income | 11.8 | 12.44 | 6.63 | 8.34 | 6.8 | 6.37 | Upgrade
|
| Net Income to Common | 11.8 | 12.44 | 6.63 | 8.34 | 6.8 | 6.37 | Upgrade
|
| Net Income Growth | 28.65% | 87.68% | -20.50% | 22.63% | 6.73% | 108.23% | Upgrade
|
| Shares Outstanding (Basic) | 3 | 3 | 3 | 3 | 3 | 3 | Upgrade
|
| Shares Outstanding (Diluted) | 3 | 3 | 3 | 3 | 3 | 3 | Upgrade
|
| Shares Change (YoY) | -0.31% | - | 16.55% | -14.24% | 0.03% | 26.66% | Upgrade
|
| EPS (Basic) | 3.60 | 3.79 | 2.02 | 2.96 | 2.07 | 1.94 | Upgrade
|
| EPS (Diluted) | 3.60 | 3.79 | 2.02 | 2.96 | 2.07 | 1.94 | Upgrade
|
| EPS Growth | 29.05% | 87.68% | -31.79% | 42.99% | 6.70% | 64.41% | Upgrade
|
| Free Cash Flow | - | 29.28 | -26.81 | -23.63 | -0.87 | 10.37 | Upgrade
|
| Free Cash Flow Per Share | - | 8.92 | -8.16 | -8.38 | -0.27 | 3.16 | Upgrade
|
| Gross Margin | 57.26% | 64.12% | 68.62% | 67.67% | 68.62% | 65.68% | Upgrade
|
| Operating Margin | 4.30% | 6.08% | -18.12% | 9.22% | 8.66% | -16.02% | Upgrade
|
| Profit Margin | 3.43% | 4.17% | 3.58% | 4.02% | 3.99% | 7.84% | Upgrade
|
| Free Cash Flow Margin | - | 9.80% | -14.47% | -11.40% | -0.51% | 12.75% | Upgrade
|
| EBITDA | 35.85 | 36.51 | -18.76 | 33 | 22.56 | -6.57 | Upgrade
|
| EBITDA Margin | 10.41% | 12.22% | -10.13% | 15.92% | 13.24% | -8.09% | Upgrade
|
| D&A For EBITDA | 21.04 | 18.37 | 14.8 | 13.9 | 7.8 | 6.45 | Upgrade
|
| EBIT | 14.82 | 18.15 | -33.56 | 19.1 | 14.75 | -13.03 | Upgrade
|
| EBIT Margin | 4.30% | 6.08% | -18.12% | 9.22% | 8.66% | -16.02% | Upgrade
|
| Effective Tax Rate | 13.31% | 11.93% | 33.94% | - | 18.28% | 23.82% | Upgrade
|
| Revenue as Reported | 348.2 | 301.86 | 238.3 | 207.9 | 170.97 | 109.63 | Upgrade
|
| Advertising Expenses | - | 0.17 | 0.42 | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.